Cite
HARVARD Citation
Martini, D. et al. (n.d.). 44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI). Journal for immunotherapy of cancer. pp. A26-A27. [Online].